Viewing Study NCT00006358


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-25 @ 10:25 PM
Study NCT ID: NCT00006358
Status: COMPLETED
Last Update Posted: 2018-06-26
First Post: 2000-10-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module